PMID: 9652391Jul 4, 1998Paper

Blockage of apoptotic signaling of transforming growth factor-beta in human hepatoma cells by carboxyfullerene

European Journal of Biochemistry
Y L HuangC K Chou

Abstract

Transforming growth factor-beta (TGF-beta) has been shown to induce apoptosis in normal hepatocytes and hepatoma cells both in vivo and in vitro. However, the mechanism by which TGF-beta induces apoptosis is not clear. The antiapoptotic activity of antioxidants including N-acetyl-L-cysteine (Ac-Cys), ascorbic acid and a novel free radical scavenger, carboxyfullerene (C60) on TGF-beta-treated human hepatoma Hep3B cells was examined. Only the water-soluble hexacarboxylic acid derivative of C60 was found to prevent TGF-beta-induced apoptosis. Antiapoptotic activity of C60 correlated its ability to eliminate TGF-beta-generated reactive oxygen species (ROSs). However, C60 did not interfere with TGF-beta-activated PAI-1 promoter activity in the Hep3B cells. These results indicate that the signaling pathway of TGF-beta-induced apoptosis may be related to the generation of ROSs and may be uncoupled from the TGF-beta-activated gene promoter activity. Furthermore, the regioisomer of C60 with a C3 symmetry was more potent in protecting cells from apoptosis than that with a D3 symmetry, and the C3 isomer had stronger interactions with lipid bilayers than the D3 isomer. The spectroscopic analysis revealed that the C3 isomer had stronger int...Continue Reading

Citations

May 29, 2009·Archives of Toxicology·Tomoyuki Sumizawa, Hideki Igisu
Dec 4, 2003·European Journal of Medicinal Chemistry·Susanna BosiMaurizio Prato
Mar 28, 2003·Biochemical and Biophysical Research Communications·Jeong Eun Kim, Minyung Lee
Jan 29, 2002·Toxicology in Vitro : an International Journal Published in Association with BIBRA·X L YangH S Zhu
May 2, 2001·Parkinsonism & Related Disorders·L L. DuganK L. O'Malley
Oct 24, 2013·ACS Applied Materials & Interfaces·Qiaoling LiuChunying Shu
Mar 23, 2002·The Journal of Antimicrobial Chemotherapy·Nina TsaoHuan-Yao Lei
May 17, 2001·Antimicrobial Agents and Chemotherapy·N TsaoH Y Lei
Dec 3, 2010·Journal of Nanoscience and Nanotechnology·Jie MengXing-Jie Liang
Jan 15, 2014·Connective Tissue Research·Qihai LiuLi Jin
Nov 9, 2000·The Journal of Investigative Dermatology·C FumelliC Pincelli
Apr 3, 2002·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Irena ManovTheodore C Iancu
Mar 10, 2018·European Journal of Drug Metabolism and Pharmacokinetics·Joshua I HardtLaura L Dugan
Jan 24, 2002·The Journal of Pharmacology and Experimental Therapeutics·Ki Young KimKi Whan Hong
Sep 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Brian GardnerSteven M Dubinett
Sep 20, 2000·The Journal of Biological Chemistry·M C ChenS L Hsieh
Sep 3, 1999·Antimicrobial Agents and Chemotherapy·N TsaoH Y Lei
Mar 18, 2021·Journal of Biotechnology·Vladimir V SharoykoKonstantin N Semenov
Apr 3, 2010·ACS Nano·Matteo Calvaresi, Francesco Zerbetto
Apr 27, 2013·ACS Applied Materials & Interfaces·Qiaoling LiuChunying Shu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.